Dr. Steven J. Jubelirer
Claim this profileWest Virginia University Charleston Division
Expert in Cancer
Studies Lung Cancer
30 reported clinical trials
78 drugs studied
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Stage III
Stage IV
Stage II
Affiliated Hospitals
Clinical Trials Steven J. Jubelirer is currently running
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Monoclonal antibodies, such as bevacizumab, may interfere with the ability of tumor cells to grow and spread. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
More about Steven J. Jubelirer
Clinical Trial Related5 years of experience running clinical trials · Led 30 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Steven J. Jubelirer has experience with
- Atezolizumab
- Paclitaxel
- Nivolumab
- Carboplatin
- Bevacizumab
- Ipilimumab
Breakdown of trials Steven J. Jubelirer has run
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Steven J. Jubelirer specialize in?
Steven J. Jubelirer focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Steven J. Jubelirer currently recruiting for clinical trials?
Yes, Steven J. Jubelirer is currently recruiting for 11 clinical trials in Charleston West Virginia. If you're interested in participating, you should apply.
Are there any treatments that Steven J. Jubelirer has studied deeply?
Yes, Steven J. Jubelirer has studied treatments such as Atezolizumab, Paclitaxel, Nivolumab.
What is the best way to schedule an appointment with Steven J. Jubelirer?
Apply for one of the trials that Steven J. Jubelirer is conducting.
What is the office address of Steven J. Jubelirer?
The office of Steven J. Jubelirer is located at: West Virginia University Charleston Division, Charleston, West Virginia 25304 United States. This is the address for their practice at the West Virginia University Charleston Division.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.